{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:50:10Z","timestamp":1780368610137,"version":"3.54.1"},"reference-count":68,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T00:00:00Z","timestamp":1722124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. pediatr. gastroenterol. nutr."],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatoxicity associated with recombinant adeno\u2010associated virus gene therapy is being increasingly encountered by hepatologists in tertiary and quaternary referral units due to the recent increase of these therapies for neuromuscular and haematological disorders. The challenges in managing the condition stem from a lack of good\u2010quality evidence on the appropriate protocols for immunosuppressants due to lack of representative animal models. There is a need for protocols for diagnosing and treating hepatotoxicity and this possible with further research to understand the problem and its management. The review also highlights the importance of a multidisciplinary team in managing hepatotoxicity and recommends further research to better identify at\u2010risk individuals, define the extent of the problem and assess the long\u2010term effects of liver injury and immunosuppressants.<\/jats:p>","DOI":"10.1002\/jpn3.12326","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T06:33:42Z","timestamp":1722234822000},"page":"485-494","source":"Crossref","is-referenced-by-count":7,"title":["Adeno\u2010associated viral vector gene therapy: Challenges for the paediatric hepatologist"],"prefix":"10.1002","volume":"79","author":[{"given":"Barath","family":"Jagadisan","sequence":"first","affiliation":[{"name":"Paediatric Liver GI and Nutrition Centre and Mowat Labs King's College Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4942-0845","authenticated-orcid":false,"given":"Anil","family":"Dhawan","sequence":"additional","affiliation":[{"name":"Paediatric Liver GI and Nutrition Centre and Mowat Labs King's College Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,7,28]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1001263"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.11.001"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.11.014"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-146546"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108046"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2020.05.044"},{"key":"e_1_2_8_8_1","unstructured":"PhilippidisA. Fourth boy dies in trial of astellas gene therapy candidate. Genetic Engineering & Biotechnology News.2023. Accessed March 2 2023.https:\/\/www.genengnews.com\/news\/fourth-boy-dies-in-trial-of-astellas-gene-therapy-candidate\/"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-019-0205-4"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11901-023-00624-5"},{"key":"e_1_2_8_11_1","unstructured":"Cellular Tissue and Gene Therapies Advisory Committee September 2\u20103 2021 Meeting Announcement. Food and Drug Administration. 2023. Accessed March 2 2023.https:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/cellular-tissue-and-gene-therapies-advisory-committee-september-2-3-2021-meeting-announcement"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2022.07.018"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.09.015"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.07.019"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2021.09.005"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2017.07.012"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37607"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24625"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.120474"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1159\/000369273"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.11.011"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-751040"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2007.001"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36891"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-167510"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.283"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI70314"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004625"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05948-2"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000829"},{"key":"e_1_2_8_31_1","unstructured":"Novartis reports Zolgensma caused two deaths from liver failure. Reuters. 2023. Accessed December 11 2023.https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/novartis-reports-zolgensma-caused-two-deaths-liver-failure-2022-08-11\/"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004415"},{"key":"e_1_2_8_33_1","unstructured":"Gene Transfer Clinical Study in X\u2010Linked Myotubular Myopathy (ASPIRO). ClinicalTrials.gov. 2023. Accessed March 2 2023.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03199469"},{"key":"e_1_2_8_34_1","unstructured":"PaulkN. Gene therapy: it's time to talk about high\u2010dose AAV. Genetic Engineering & Biotechnology News. 2023. Accessed March 2 2023.https:\/\/www.genengnews.com\/commentary\/gene-therapy-its-time-to-talk-about-high-dose-aav\/"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199903)45:3<337::AID-ANA9>3.0.CO;2-U"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01075-12"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410200615"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0887-8994(94)00100-G"},{"key":"e_1_2_8_39_1","unstructured":"FDA approves first gene therapy to treat adults with hemophilia B. Food and Drug Administration. 2023. Accessed March 2 2023.https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-gene-therapy-treat-adults-hemophilia-b"},{"key":"e_1_2_8_40_1","unstructured":"First gene therapy to treat haemophilia B. European Medicines Agency. 2023. Accessed February 1 2023.https:\/\/www.ema.europa.eu\/en\/news\/first-gene-therapy-treat-haemophilia-b"},{"key":"e_1_2_8_41_1","unstructured":"First gene therapy to treat severe haemophilia A. European Medicines Agency. 2023. Accessed March 2 2023.https:\/\/www.ema.europa.eu\/en\/news\/first-gene-therapy-treat-severe-haemophilia"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1351-8216.2003.00828.x"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.07.006"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708538"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-118334"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112471"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2012.01.004"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211644"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-143560"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2012.55"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1089\/humc.2017.146"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1089\/humc.2015.068"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2014.33"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2005056"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2017.01.003"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29176"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25579"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2214084"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2010.222"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-122"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-017913"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00082"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.021"},{"key":"e_1_2_8_64_1","unstructured":"Guidance for industry. Drug\u2010induced liver injury: premarketing clinical evaluation. U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER). Accessed March 2 2023.https:\/\/www.fda.gov\/media\/116737\/download"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.03.009"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.01.007"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.10.018"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3389"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.06.001"}],"container-title":["Journal of Pediatric Gastroenterology and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jpn3.12326","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T16:16:51Z","timestamp":1727281011000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jpn3.12326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,28]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1002\/jpn3.12326"],"URL":"https:\/\/doi.org\/10.1002\/jpn3.12326","archive":["Portico"],"relation":{},"ISSN":["0277-2116","1536-4801"],"issn-type":[{"value":"0277-2116","type":"print"},{"value":"1536-4801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,28]]}}}